Richard Beckman - Net Worth and Insider Trading
Richard Beckman Net Worth
The estimated net worth of Richard Beckman is at least $29,256 dollars as of 2024-06-11. Richard Beckman is the Chief Medical Officer of Adverum Biotechnologies Inc and owns about 3,906 shares of Adverum Biotechnologies Inc (ADVM) stock worth over $29,256. Details can be seen in Richard Beckman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Richard Beckman has not made any transactions after 2022-09-19 and currently still holds the listed stock(s).
Transaction Summary of Richard Beckman
Richard Beckman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard Beckman owns 1 companies in total, including Adverum Biotechnologies Inc (ADVM) .
Click here to see the complete history of Richard Beckman’s form 4 insider trades.
Insider Ownership Summary of Richard Beckman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADVM | Adverum Biotechnologies Inc | 2022-09-19 | Chief Medical Officer |
Richard Beckman Latest Holdings Summary
Richard Beckman currently owns a total of 1 stock. Richard Beckman owns 3,906 shares of Adverum Biotechnologies Inc (ADVM) as of September 19, 2022, with a value of $29,256.
Latest Holdings of Richard Beckman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ADVM | Adverum Biotechnologies Inc | 2022-09-19 | 3,906 | 7.49 | 29,256 |
Holding Weightings of Richard Beckman
Richard Beckman Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard Beckman has made a total of 2 transactions in Adverum Biotechnologies Inc (ADVM) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Adverum Biotechnologies Inc is the sale of 427 shares on September 19, 2022, which brought Richard Beckman around $4,571.
Insider Trading History of Richard Beckman
- 1
Richard Beckman Trading Performance
GuruFocus tracks the stock performance after each of Richard Beckman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard Beckman is 62.98%. GuruFocus also compares Richard Beckman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard Beckman within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard Beckman's insider trading performs compared to the benchmark.
Performance of Richard Beckman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 20.73 | | | | | |
| Relative Return to S&P 500(%) | 30.86 | | | | | |
Richard Beckman Ownership Network
Richard Beckman Owned Company Details
What does Adverum Biotechnologies Inc do?
Who are the key executives at Adverum Biotechnologies Inc?
Richard Beckman is the Chief Medical Officer of Adverum Biotechnologies Inc. Other key executives at Adverum Biotechnologies Inc include Chief Development Officer Setareh Seyedkazemi , Chief Financial Officer Linda M Rubinstein , and Chief Scientific Officer Brigit Riley .
Adverum Biotechnologies Inc (ADVM) Insider Trades Summary
Over the past 18 months, Richard Beckman made no insider transaction in Adverum Biotechnologies Inc (ADVM). Other recent insider transactions involving Adverum Biotechnologies Inc (ADVM) include a net purchase of 130,000 shares made by Lupher, Jr. Mark L. , a net purchase of 100,000 shares made by James Paul Scopa , and a net purchase of 100,000 shares made by Linda M Rubinstein .
In summary, during the past 3 months, insiders sold 0 shares of Adverum Biotechnologies Inc (ADVM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,810 shares of Adverum Biotechnologies Inc (ADVM) were sold and 33,000 shares were bought by its insiders, resulting in a net purchase of 26,190 shares.
Adverum Biotechnologies Inc (ADVM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adverum Biotechnologies Inc Insider Transactions
Richard Beckman Mailing Address
Above is the net worth, insider trading, and ownership report for Richard Beckman. You might contact Richard Beckman via mailing address: C/o Adverum Biotechnologies, Inc., 100 Cardinal Way, Redwood City Ca 94063.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
